District "5213" Program

District-leading youth innovation and entrepreneurship teams: up to RMB 8 million subsidy.
Innovation and entrepreneurship teams: up to RMB 20 million

Newly introduced NEEQ-listed companies receive a one-time RMB 2million subsidy.
Listed companies relocating from outside the district receive RMB 10 million.

For national or provincial key science and tech projects, 25% of actual funds will be subsidized, up to RMB 5 million.

For annual R&D expenditure exceeding RMB 10 million, 10% will be subsidized, capped at RMB 5 million For annual R&D expenditure.

For technology transfer, up to 5% of the annual transaction value will be rewarded, capped at RMB 2 million.

30% of investment in R&D equipment and software will be subsidized,capped at RMB 20 million

Up to 20% of the awarded funding amount for innovation and entrepre-neurship projects can be used as renovation subsidies, capped at RMB 3million.

For district-level and above events, 50% of actual expenses will be subsidized (max RMB 500,000 per event); for other events, 10% of costs will be subsidized.

or Category C and above talents settling in the town: 30% tuition sulbsidy (up to RMB 60,000/year); others receive 15% (up to RMB 30,000/year)

For city-level A-E talent categories: A-level evaluated case by case; B-E levels receive living subsidies ranging from RMB 30,000 to 200,000 For talents under the district's "Golden Phoenix" program: fresh graduates receive RMB 40,000 (Bachelor), RMB 60,000 (Master), and RMB 80,000 (PhD) living subsidies respectively

High-end medical device R&D projects receive 20% subsidy, up to RMB 10 million.

Newly approved Class Il/ill medical device registrations receive RMB500,000 / 1,000,000 in rewards. CFDA standard registration clinical trialcosts subsidized up to RMB 1 million. CFDA priority registration clinical trial costs subsidized up to RMB 2 milion.

For enterprises that obtain national drug or medical device registration certificates and proceed with industrialization, each medical aesthetic drug variety is eligible for a reward of up to RMB 5 million; each Class Ill medical aesthetic device variety is eligible for a reward of up to RMB 1million; and each Class Il medical aesthetic device variety is eligible for a reward of up to RMB 500,000.
For products that are put into production and generate sales within threeyears after obtaining certification, enterprises whose annual salescontinue to grow may receive an additional reward based on incrementalannual sales: For every RMB 10 million increase in annual sales, a rewardof up to RMB 500,000 will be granted. The total annual reward per enterprise shall not exceed RMB 5 million.

Academician-level experts receive RMB 5 million in living subsidies;projects led by academicians may receive up to RMB 100 million in support.

A-D category talents in Hangzhou are eligible for housing subsidies ranging from RMB 1 to 8 million.

For city-level A-E talent categories: A-level evaluated case by case; B-Elevels receive living subsidies ranging from RMB 30,000 to 200,000
For talents under the district's

Innovative drug projects are eligible for 20% R&D subsidy, capped at RMB 10 million; rental and renovation subsidies included.

For CXO/CDMO and other biopharmaceutical public service platforms,30% of investment is subsidized, with a cap of RMB 20 million; rental and renovation subsidies also provided.

Completion of Phase I clinical trials: up to RMB 10 million subsidy;
PhaseII: up to RMB 20 million;
Phase IIl: up to RMB 40 million.